FEATURED PRODUCTS

• Powering Production Of Viral Vector-Based Therapies

  Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.

• CD34+ HSC LNP Kits

  Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.

• GenVoy-ILM™ T-Cell Kits For mRNA

  Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.

• A Comprehensive Upstream Platform For Gene Therapy Applications

  Explore a variety of cell lines, high-performance cell culture media, and single-use bioreactors to suit your process needs for any cell type.

• AAV Manufacturing Workflow

  Explore scalable and flexible single-use solutions from design to delivery that can help you overcome challenges throughout adeno-associated virus (AAV) manufacturing workflow.

• Single-Use System For Clinical And Commercial Production Of LNPs

  Learn about a scalable, single-use platform with built-in automation and regulatory compliance that enables standardized manufacturing workflows for mRNA-LNP drug product production.

• Automated, Single-Use System For Clinical And Commercial LNP Production

  The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions. Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.

• Services For Advancing mRNA-LNPs From Bench To Clinic

  Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.

• Complete Solutions For Every Step Of Pharmaceutical Development

  By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products.

• A Disruptive Technology Accelerating Drug Development

  Ignite simplifies the transition into clinical programs by incorporating these fundamental process steps for scale up in the earliest stages of pre-clinical development.

   

• GenVoy-ILM™ T Cell Kit For mRNA, Ignite™

  GenVoy-ILM™ T Cell Kit for mRNA, Ignite is an lipid nanoparticle (LNP) reagent mix optimized for the delivery of messenger RNA (mRNA) or Cas9 mRNA/sgRNA into activated human primary T cells.

• A Next-Generation Technology For The Power To Scale

  With NxGen™ technology on the NanoAssemblr^® Blaze™, important studies can be conducted efficiently with a process that mirrors a clinical scale implementation.

• T Cell Kit For mRNA On NanoAssemblr Spark

  The GenVoy-ILM T Cell Kit for mRNA is optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr Spark instrument and cartridges.

• NanoAssemblr® GMP System: Power To Commercialize

  Built on our revolutionary NxGen™ technology found in our NanoAssemblr^® family of instruments, the NanoAssemblr^® GMP System enables you to go from concept to clinic with speed and confidence.

• GenVoy-ILM™: Power To Explore

  GenVoy-ILM is a pre-optimized lipid mixture designed to encapsulate RNA – mRNA, gRNA, siRNA, miRNA, tRNA – in LNP.

• NanoAssemblr® Spark™: Freedom To Discover

  The NanoAssemblr^® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.